Valneva SE (EPA:VLA)
France · Delayed Price · Currency is EUR 2.399
-0.073 (-2.95%)
Oct 22, 2026, 5:35 PM CEST
Valneva SE Market Cap
Valneva SE has a market cap or net worth of €454.96 million as of October 22, 2026. It is the 14,256th most valuable company in the world and the 190th biggest in France. Its market cap has decreased by 36.71% in one year.
Market Cap
454.96M
Enterprise Value
543.67M
Revenue
142.94M
Global Rank
Country Rank
#190 France
PE Ratio
n/a
ChartMarket Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 99.08M to 454.96M, an increase of 359.20%. That is a compound annual growth rate of 8.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 454.96M | -29.17% |
| Dec 31, 2025 | 642.32M | 82.94% |
| Dec 31, 2024 | 351.10M | -46.40% |
| Dec 29, 2023 | 655.08M | -23.93% |
| Dec 30, 2022 | 861.12M | -66.55% |
| Dec 31, 2021 | 2.57B | 265.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MedinCell | 960.99M |
| Nanobiotix | 938.49M |
| Inventiva | 645.04M |
| DBV Technologies | 470.21M |
| Genfit | 417.26M |
| Valerio Therapeutics Société anonyme | 206.52M |
| Transgene | 187.06M |
| Innate Pharma | 118.25M |